Immunome
(NASDAQ:IMNM)
$14.77
-0.03[-0.20%]
Last update: 7:06AM Get Real Time Here
Q1 2024 Earnings were released on Tue May 14th, before the market open

Immunome Stock (NASDAQ:IMNM), Guidance and Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Get Alert
No data available to display

FAQ

Q

What is the most recent guidance for Immunome (IMNM)?

A

There have been no specific sales or earnings guidance reported for Immunome in recent months.

Browse guidance and forecast on all stocks.

People Also Watch